Jane Street Group, LLC Harrow Health, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 132,633 shares of HROW stock, worth $4.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,633

Previous 110,570 19.95%

Holding current value

$4.65 Million

Previous $2.31 Million 158.25%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.85 - $46.47 $460,013 - $1.03 Million	22,063 Added 19.95%	132,633 $5.96 Million
Q2 2024 Aug 14, 2024	BUY	$10.0 - $21.64 $889,680 - $1.93 Million	88,968 Added 411.85%	110,570 $2.31 Million
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $469,464 - $667,850	-50,480 Reduced 70.03%	21,602 $285,000
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $583,864 - $1.18 Million	72,082 New	72,082 $807,000
Q2 2023 Aug 14, 2023	SELL	$17.37 - $28.08 $986,094 - $1.59 Million	-56,770 Reduced 31.05%	126,055 $2.4 Million
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $1.59 Million - $2.47 Million	115,098 Added 169.94%	182,825 $3.87 Million
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $696,233 - $1 Million	67,727 New	67,727 $999,000
Q2 2022 Aug 16, 2022	SELL	$5.75 - $7.74 $90,717 - $122,113	-15,777 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$6.77 - $8.66 $106,810 - $136,628	15,777 New	15,777 $108,000
Q3 2021 Nov 16, 2021	SELL	$6.99 - $10.6 $287,414 - $435,850	-41,118 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $274,668 - $455,176	41,118 New	41,118 $382,000
Q4 2020 Feb 17, 2021	SELL	$4.76 - $6.93 $48,509 - $70,623	-10,191 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$4.71 - $7.36 $164,341 - $256,805	-34,892 Reduced 77.4%	10,191 $57,000
Q2 2020 Aug 17, 2020	BUY	$3.61 - $6.47 $21,468 - $38,477	5,947 Added 15.2%	45,083 $235,000
Q1 2020 May 15, 2020	BUY	$3.5 - $7.31 $136,976 - $286,084	39,136 New	39,136 $149,000
Q2 2019 Aug 15, 2019	SELL	$4.2 - $8.7 $73,164 - $151,554	-17,420 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$4.75 - $7.1 $82,745 - $123,682	17,420 New	17,420 $87,000

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $950M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Harrow Health, Inc. Transaction History